Discovery of pan-antagonist ligands
for the melanocortin receptors
will help identify the physiological activities controlled by these
receptors. The previously reported MC3R/MC4R antagonist Ac-DPhe(pI)-Arg-Nal(2′)-Arg-NH2 was identified herein, for the first time, to possess MC1R
and MC5R antagonist activity. Further structure–activity relationship
studies probing the second and fourth positions were performed toward
the goal of identifying potent melanocortin antagonists. Of the 21
tetrapeptides synthesized, 13 possessed MC1R, MC3R, MC4R, and MC5R
antagonist activity. Three tetrapeptides were more than 10-fold selective
for the mMC1R, including 8 (LTT1-44, Ac-DPhe(pI)-DArg-Nal(2′)-Arg-NH2) that possessed 80 nM mMC1R antagonist potency and was at
least 40-fold selective over the mMC3R, mMC4R, and mMC5R. Nine tetrapeptides
were selective for the mMC4R, including 14 [SSM1-8, Ac-DPhe(pI)-Arg-Nal(2′)-Orn-NH2] with an mMC4R antagonist potency of 1.6 nM. This compound
was administered IT into mice, resulting in a dose-dependent increase
in the food intake and demonstrating the in vivo utility of this compound
series.